by Richard Daverman, PhD
March 29, 2013 -- Sinopharm Group, the biggest drug distributor in China, will raise $515 million by selling new Hong Kong-listed shares. The company said it would use the money to expand its sales network, which probably means a new round of M&A in China’s distribution sector. Because Sinopharm’s growth plans are so extensive, the company will be back in the market for more capital later this year, according to one analyst. More details....
Stock Symbol: (HK: 1099)
